Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDGL · as of Jun 8, 2026
Key Statistics
Explore Madrigal Pharmaceuticals, Inc. Data
mdgl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 23 · Buy rate: 87.0%
The MDGL analyst consensus is Buy, based on ratings from 23 Wall Street analysts over the past 3 months. The average 12-month price target is $731.25, representing +50.16% upside from the current price of $486.98.
Competitors & Peers
mdgl competitorsMDGL
ABVX
BAX
BMRN
CAI
EXELStock Performance
Full HistoryAbout Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, a…
what is madrigal pharmaceuticals, inc. · mdgl stock overview · madrigal pharmaceuticals, inc. company profile · who is madrigal pharmaceuticals, inc. ceo · mdgl NASDAQ · madrigal pharmaceuticals, inc. headquarters · madrigal pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Madrigal Pharmaceuticals, Inc. (MDGL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 6, 2007. As of the latest trading session, MDGL stock price is $486.98, with a market capitalization of $11.2B. The stock has returned +73.77% over the past 12 months and -16.38% year-to-date.
According to 23 Wall Street analysts, the consensus rating for Madrigal Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $731.25. In fiscal year 2025, Madrigal Pharmaceuticals, Inc. reported revenue of $958.4M and net income of -$288.3M. For detailed data — including Madrigal Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Madrigal Pharmaceuticals, Inc. (MDGL) stock price is $486.98. The stock is traded on NASDAQ under the ticker symbol MDGL. The 52-week range is $271.96 – $615.00.